CD79A and stroke disorder: In contrast to the short half-life of IgA and IgM21–23, the half-lives of IgG1 and IgG4 are reported to be 21 days and therefore, an early reduction in IgG concentration is not compatible with a lack ofde novo production after stroke due to loss of B cells24.